Janssen Pharmaceutic Products sent a two-page letter to the health care community this past week to clarify the risks of Risperdal, Carol Goodrich, a spokeswoman for the Johnson & Johnson subsidiary, said Saturday.
This post currently has
You can read the comments or leave your own thoughts.
Last reviewed: By John M. Grohol, Psy.D. on 27 Jul 2004
Published on PsychCentral.com. All rights reserved.
Grohol, J. (2004). Drug Maker Acknowledges Misleading Claims. Psych Central. Retrieved on December 8, 2013, from http://psychcentral.com/blog/archives/2004/07/27/drug-maker-acknowledges-misleading-claims/